期刊文献+

补肾通络方对去卵巢大鼠破骨细胞组织蛋白酶K表达的影响 被引量:7

Effect of Bushen Tongluo Prescription on Osteoclast Cathepsin K in Ovariectomized Rats
原文传递
导出
摘要 【目的】探讨组织蛋白酶K(cathepsin K,CK)在骨质疏松症发病中的意义,观察补肾通络方对去卵巢大鼠破骨细胞CK表达的影响。【方法】选用30只雌性SD大鼠随机分成3组:假手术组、模型组及补肾通络方组(中药组,剂量为12.46 g.kg-1.d-1);后2组切除双侧卵巢,4周后中药组给予补肾通络方灌胃。分别于第6、12周测定各组大鼠全身骨密度(BMD),并采用Western blot及逆转录—聚合酶链反应(RT-PCR)法测定体外分离培养破骨细胞中CK的蛋白及基因表达。【结果】体外分离培养椎骨来源的破骨细胞具有成熟破骨细胞的表型特征,去卵巢模型大鼠骨密度在时效上与CK的表达呈现负相关;补肾通络方以时效方式下调CK蛋白及CK mRNA的表达水平(均P<0.05)。【结论】CK的过度表达是导致骨密度下降的重要原因,是骨质疏松症发生的潜在危险因子;以时效方式下调CK蛋白及CK mRNA的表达进而治疗骨质疏松症可能是补肾通络方的作用机制之一。 Objective To approach the effect of cathepsin K(CK) on the onset of osteoporosis,and to study the influence of Bushen Tongluo Prescription(BTP,with the actions of invigorating the kidney and dredging the meridians) on osteoclast CK in ovariectomized rats.Methods Thirty female SD rats were divided into three groups randomly: sham-operation group,model group and BTP(12.46g.kg-1.d-1) group.The bilateral ovaries in rats of the model group and BTP group were removed.Four weeks later,BTP group were given gastric gavage of BTP.On the 6th and 12th weeks,we detected the general bone density of rats,examined CK expressionin osteoclasts with Western blot and reverse transcription-polymerase chain reaction(RT-PCR) methods.ResultsThe in-vitro cultured cells had the phenotype feature of mature osteoclasts.The bone mineral density of ovariectomized rats was negatively correlated with CK expression in time-effect manner.BTP down-regulated the CK protein and CK mRNA expression(P〈0.05) in time-effect manner.Conclusion CK overexpression contributes to the decrease of bone mineral density,which is one of the potential risk factors of osteoporosis.Down-regulation of CK protein and CK mRNA expression in time-effect manner is probably one of the therapeutic mechanisms of BTP for osteoporosis.
出处 《广州中医药大学学报》 CAS 2010年第4期371-374,383,439,共6页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 广东省自然科学基金项目(编号:815104701000050)
关键词 骨质疏松症/中药疗法 补肾通络方/药理学 组织蛋白酶K 破骨细胞/病理学 疾病模型 动物 大鼠 OSTEOPOROSIS/TCD therapy BUSHEN TONGLUO PRESCRIPTION/pharmacology CATHEPSIN K OSTEOCLAST/pathology DISEASE MODELS ANIMAL RATS
  • 相关文献

参考文献8

  • 1D'alessio K J, McQueney M S, Brun K A, e tal. Expression in Escherichia coli, refoltting, and purification of human procathepsin K, an osteoclast-specific protease [J]. Protein Expr Purif, 1999, 15 (2): 213.
  • 2Elbashir S M, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interference RNAs [J]. Methods, 2002, 26 (2): 199.
  • 3吴启跃,马雯,余正红,雷洋洋,李钦宗.骨质疏松两种造模方法的对照研究[J].中国中医骨伤科杂志,2007,15(8):17-19. 被引量:10
  • 4何涛,杨庆铭,邓廉夫.成人破骨细胞骨髓培养法的建立与鉴定[J].中华骨科杂志,1999,19(1):59-61. 被引量:6
  • 5Lewiecki E M. Managing osteoporosis: Challenges and strategies [ J ]. Cleveland Clinic Journal of Medicine, 2009, 76 : 457.
  • 6Evens V, Hou W S, Rialland X, et al. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts [ J]. Calcified Tissue International, 2003, 73 (4): 380.
  • 7Drake F H, Dodds R A, James I E, et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J], J Biol Chem, 1996, 24: 271.
  • 8Rodan S B, Duong L T. Cathepsin K-A new molecular target for osteoporosis [J]. IBMS Bone Key, 2008, 5 (1): 16.

二级参考文献11

  • 1史凤芹,于世凤.体外破骨细胞分离培养方法的建立[J].中华骨科杂志,1994,14(1):43-46. 被引量:28
  • 2于明香,金慰芳,王洪复,关本博,林光义.破骨细胞体外培养与形态观察[J].上海医科大学学报,1996,23(1):52-54. 被引量:19
  • 3于明香,上海医科大学学报,1996年,23卷,52页
  • 4史凤芹,中华骨科杂志,1994年,14卷,43页
  • 5INMAN C L,WARREN G L,HOGAN H A,et al.Mechanical loading attenuates bone loss due to immobilization and calcium deficiency[J].J Appl Physiol,1999,87 (1):189-195.
  • 6MANELLI F,GIUSTINA A.Glucocorticoid induced osteoporosis[J].T rends Endocrinol M etab,2000,11(3):79-85.
  • 7XIE H,LI ON,HUANG L F,et al.Effect of total coumarins from dried fruits of Cnidium monnierion glucocortico id2induced o steoporosis in Rats[J].Zhong guo Yao Li Xue Bao,1994,15(4):3712-3741.
  • 8OHSAKI Y,TAKAHASHI S,SCARCEZ T,et al.Evidence of an autocrine paracrcrine role for interleukin in bone[J].Endocrinol ogy,1992,131(5):2229-2234.
  • 9MARK C H.Cytokines and estrogen inbone:anti osteoportic effects.Science,1993,260(30):626-627.
  • 10BURGESS A W.Epidermal growth factor and transforming growth factory[J].Br MedBull,1989,45(2):401-424.

共引文献14

同被引文献134

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部